Delivery Order HHSN272201300003I-HHSN27200003
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $3.14 million to Bioqual, Inc. for the conduct of Study P172 under the Simian Vaccine Evaluation Units master IDIQ contract (2013-2020). This cost-plus-fixed-fee delivery order, awarded May 1, 2013, with an ultimate completion date of April 22, 2023, supports NIAID's research infrastructure for evaluating vaccine candidates and countermeasures against infectious diseases using non-human primate...
- Bioqual, Inc., a biomedical research services company based in Rockville, Maryland, was awarded a delivery order valued at $2.77 million for core administrative and technical support services under the Simian Vaccine Evaluation Units (SVEUS) program. This cost-plus-fixed-fee delivery order, issued by the National Institute of Allergy and Infectious Diseases (NIAID), commenced on April 1, 2020, and will conclude on March 31, 2027. The work is being performed at Bioqual's facility in Rockville,...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $1.41 million to Bioqual, Inc. for the maintenance of non-human primates in an ABSL2/3 (Animal Biosafety Level 2/3) facility under the Simian Vaccine Evaluation Units (SVEU) program. The contract, awarded April 1, 2020, with an ultimate completion date of March 31, 2027, is structured as a cost-plus-fixed-fee delivery order with no set-aside designation. Bioqual, a for-profit biomedical...
- This is a $608,420.77 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. for "SIMIAN VACCINE EVALUATION UNITS". The contract is a task order issued under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Bioqual, a for-profit organization, provides animal research support services including housing, care, and testing for...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $782,160.63 to Bioqual, Inc. for the conduct of Study P218. This unilateral modification (Amendment 2) updates Federal Procurement Data System (FPDS) reporting processes to ensure compliance with a Presidential Memorandum regarding radical transparency about wasteful spending. The contract utilizes a cost-plus-fixed-fee pricing structure with a completion date of June 4, 2024. Bioqual, Inc., a...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bioqual, Inc. as the prime contractor. The contract, valued at $544,999.84, is for the housing and maintenance of non-human primates in support of biomedical research. This award falls under Bioqual's existing Simian Vaccine Evaluation Units (SVEU) indefinite-delivery/indefinite-quantity (IDIQ) contract with NIAID, which...
- This is a federal contract award to Bioqual, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, for "SIMIAN VACCINE EVALUATION UNITS". The contract has a ceiling value of $4,398,713.69 and an ultimate completion date of September 13, 2024. The contract is a Delivery Order under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle, which allows for task orders related to primate vaccine...
- This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bioqual, Inc. for $3,067,182.00 to provide housing and maintenance of laboratory animals for NIAID's Vaccine Research Center (VRC). The contract was set aside for small businesses and has an ultimate completion date of September 27, 2019. Bioqual, Inc. is a fully accredited company that provides...
- This is a $294,760.24 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract. The contract is for SIMIAN VACCINE EVALUATION UNITS and does not have a set-aside designation. Bioqual is a prime contractor that provides animal research services, including housing and caring for nonhuman primates,...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Bioqual, Inc. on November 17, 2011, with a ceiling value of $627,844.82 under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ for non-human primate models to support filovirus vaccine efficacy testing. The order is priced on a cost-plus-fixed-fee basis and performance takes place in Rockville, MD. The ultimate completion date is November 30, 2013. Bioqual provides biomedical research services and...
- Simian Vaccine Evaluation Units 2013-2020Master IDIQ
- HHSN272201300003IIndefinite Delivery Contract
- HHSN272201300003I-HHSN27200003Delivery Order
Bioqual, Inc. was awarded a delivery order valued at $1.41 million by the National Institute of Allergy and Infectious Diseases (NIAID) on May 1, 2013, for Simian Vaccine Evaluation Units. This cost-plus-fixed-fee contract, which concluded on April 30, 2015, was performed in Potomac, Maryland, and represents work under the broader Simian Vaccine Evaluation Units 2013-2020 indefinite delivery vehicle. No set-aside designation was applied to this award, allowing Bioqual to compete in the open federal procurement process. NIAID, a component of the National Institutes of Health, funds this work as part of its mission to conduct and support research on infectious diseases and vaccine development. Bioqual, a biomedical research services company based in Rockville, Maryland, specializes in providing advanced scientific research support to federal agencies, with particular expertise in preclinical animal studies and laboratory analysis. The company's substantial track record with NIAID includes multiple contract vehicles focused on developing and evaluating animal models for infectious disease countermeasures, including non-human primate models critical to vaccine evaluation efforts. This delivery order aligns with Bioqual's core competencies in supporting sophisticated vaccine development research through specialized animal model work and experimental study services.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
SIMIAN VACCINE EVALUATION UNITS | RFP-NIAID-DAIDS-NIHAI2012138 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 5/21/12, 3:03 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Funding Only Action | ($25k) | 4/9/18 | |
| 1 | Change Order | $359.1k | 9/26/13 | |
| Not listed | Not listed | $1.1m | 4/30/13 |